MindMed to Participate in Upcoming Investor Conferences
MindMed (NASDAQ: MNMD), a clinical-stage biopharmaceutical company focused on brain health disorders, has announced its participation in two upcoming investor conferences. The company will attend the Jefferies London Healthcare Conference for one-on-one meetings on November 20-21, 2024, in London, UK. Additionally, MindMed will participate in the 7th Annual Evercore HealthCONx Conference on December 5, 2024, in Coral Gables, FL, featuring a fireside chat at 11:15 PM ET. Audio webcasts and replays will be available on MindMed's Investor Relations website for 90 days after each event.
MindMed (NASDAQ: MNMD), un'azienda biofarmaceutica in fase clinica specializzata nei disturbi della salute mentale, ha annunciato la sua partecipazione a due conferenze per investitori imminenti. L'azienda sarà presente alla Jefferies London Healthcare Conference per incontri uno a uno il 20 e 21 novembre 2024, a Londra, Regno Unito. Inoltre, MindMed parteciperà alla 7th Annual Evercore HealthCONx Conference il 5 dicembre 2024, a Coral Gables, FL, dove si svolgerà una conversazione informale alle 11:15 PM ET. Le registrazioni audio delle conferenze e le repliche saranno disponibili sul sito web delle Relazioni con gli Investitori di MindMed per 90 giorni dopo ogni evento.
MindMed (NASDAQ: MNMD), una empresa biofarmacéutica en etapa clínica centrada en los trastornos de la salud cerebral, ha anunciado su participación en dos conferencias para inversores que se aproximan. La empresa asistirá a la Jefferies London Healthcare Conference para reuniones uno a uno el 20 y 21 de noviembre de 2024, en Londres, Reino Unido. Además, MindMed participará en la 7th Annual Evercore HealthCONx Conference el 5 de diciembre de 2024, en Coral Gables, FL, que contará con una charla informal a las 11:15 PM ET. Las transmisiones de audio y repeticiones estarán disponibles en el sitio web de Relaciones con Inversores de MindMed durante 90 días después de cada evento.
MindMed (NASDAQ: MNMD), 뇌 건강 장애에 초점을 맞춘 임상 단계의 생명공학 회사가 두 개의 예정된 투자자 컨퍼런스에 참여한다고 발표했습니다. 이 회사는 2024년 11월 20-21일 영국 런던에서 열리는 Jefferies London Healthcare Conference에 일대일 미팅을 위해 참석할 예정입니다. 또한, MindMed는 2024년 12월 5일 플로리다주 코랄게이블스에서 열리는 7th Annual Evercore HealthCONx Conference에도 참여하여 오후 11:15 ET에 대담을 진행할 것입니다. 각 행사 후 90일 동안 MindMed의 투자자 관계 웹사이트에서 오디오 웹캐스트와 재생을 이용할 수 있습니다.
MindMed (NASDAQ: MNMD), une entreprise bio-pharmaceutique en phase clinique axée sur les troubles de la santé mentale, a annoncé sa participation à deux prochaines conférences pour investisseurs. L'entreprise assistera à la Jefferies London Healthcare Conference pour des réunions individuelles les 20 et 21 novembre 2024, à Londres, au Royaume-Uni. De plus, MindMed participera à la 7th Annual Evercore HealthCONx Conference le 5 décembre 2024, à Coral Gables, FL, avec une discussion informelle prévue à 23h15 ET. Des webcasts audio et des rediffusions seront disponibles sur le site Web des relations avec les investisseurs de MindMed pendant 90 jours après chaque événement.
MindMed (NASDAQ: MNMD), ein biopharmazeutisches Unternehmen in der klinischen Phase, das sich auf Störungen der Gehirngesundheit konzentriert, hat seine Teilnahme an zwei bevorstehenden Investorenkonferenzen angekündigt. Das Unternehmen wird an der Jefferies London Healthcare Conference am 20. und 21. November 2024 in London, UK, an einem persönlichen Treffen teilnehmen. Darüber hinaus wird MindMed an der 7th Annual Evercore HealthCONx Conference am 5. Dezember 2024 in Coral Gables, FL, teilnehmen, wo um 11:15 PM ET ein informelles Gespräch stattfindet. Audio-Webcasts und Wiederholungen werden 90 Tage nach jeder Veranstaltung auf der Website der Investor Relations von MindMed verfügbar sein.
- None.
- None.
-
Jefferies London Healthcare Conference
- Format: 1x1 Meetings
- Dates: November 20-21, 2024
-
Location:
London, UK
-
7th Annual Evercore HealthCONx Conference
- Format: Fireside Chat and 1x1 Meetings
- Date and Time: Thursday, December 5, 2024 at 11:15 PM ET
-
Location:
Coral Gables, FL - Webcast Link: 7th Annual Evercore HealthCONx Conference
Audio webcasts and replays of available presentations will be accessible on MindMed’s Investor Relations website for up to 90 days following each event.
About MindMed
MindMed is a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders. Our mission is to be the global leader in the development and delivery of treatments that unlock new opportunities to improve patient outcomes. We are developing a pipeline of innovative product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways that play key roles in brain health. MindMed trades on NASDAQ under the symbol MNMD.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241113954608/en/
For Media: media@mindmed.co
For Investors: ir@mindmed.co
Source: Mind Medicine Inc.
FAQ
When is MindMed (MNMD) participating in the Jefferies London Healthcare Conference 2024?
What time is MindMed's (MNMD) presentation at the Evercore HealthCONx Conference 2024?
How long will MindMed's (MNMD) conference webcasts be available for viewing?
